Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01406990 · ClinicalTrials.gov registry record
Aspirin Responsiveness in Women With Coronary Artery Disease
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 15
- Enrollment target
NCT01406990: Completed study, sponsored by Creighton University.
NCT01406990 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01406990 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the percentage of women with known Coronary Artery Disease (CAD) who are hyporesponsive to low dose (81 mg) aspirin.
Primary Outcome
Hyporesponsive was defined as Aspirin Response Unit (ARU) \> 550 equating to less than 50% platelet inhibition.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-04 |
What the finished NCT01406990 record still lists
NCT01406990 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01406990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01406990 about?
NCT01406990 is a clinical study titled "Aspirin Responsiveness in Women With Coronary Artery Disease". The purpose of this study is to measure the percentage of women with known Coronary Artery Disease (CAD) who are hyporesponsive to low dose (81 mg) aspirin.
What is the current status of trial NCT01406990?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2011-06. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT01406990?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia